Organisation paid for research Program year 2025 Source: CMS Open Payments

Baptist Health

Neither a doctor nor a teaching hospital

Research payments

$816,650

22 payments

Through program year 2025, Baptist Health is reported as receiving $816,650 in research payments, across 22 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $81,095 5
2024 Research $329,834 5
2023 Research $393,733 3
2022 Research $500 1
2021 Research $6,577 6
2019 Research $4,913 2

Breakdown

Who paid Research payments · program years 2019–2025
  1. AstraZeneca UK Limited $589,706 2 payments
  2. Eli Lilly and Company $158,400 10 payments
  3. AstraZeneca Pharmaceuticals LP $56,556 1 payment
  4. Boston Scientific Corporation $6,127 4 payments
  5. Philips Electronics North America Corporation $4,913 2 payments
  6. Aziyo Biologics, Inc. $500 1 payment
  7. Allergan Inc. $450 2 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Phase I-III Randomized Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156-AZD3152 for Pre exposure Prophylaxis of COVID 19 in Participants with Conditions Causing Immune Impairment $589,706 2 payments
  2. A Study of Retatrutide (Ly3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity Or Overweight (Triumph-2) $59,325 4 payments
  3. A Phase III Randomized Double-blind Placebo-controlled Multi-center Study in Adults to Determine the Safety and Efficacy of AZD7442 a Combination Product of Two Monoclonal Antibodies (AZD8895 and AZD1061) for Pre-exposure Prophylaxis of COVID-19 $56,556 1 payment
  4. A Study of Ly3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain $51,818 1 payment
  5. A Study of Ly3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain $27,855 3 payments
  6. An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone Or in Combination With Mirikizumab for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis $18,361 1 payment
  7. Preempt HF $6,127 4 payments
  8. Caro $4,913 2 payments
  9. A Study of Ly3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain $1,041 1 payment
  10. CLP-0004 - SimpliDerm $500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record